Dr. Armiger has over 45 years of technical and business experience in chemicals, pharmaceuticals and biotechnology.

He began his career by founding BioChem Technology, a research and development company developing, licensing, and commercializing products and technology for use in bioprocessing. His career has also included positions with Arthur D. Little, The Catalyst Group, and Venture Catalysts. Dr. Armiger, founder of BioChemInsights, Inc., has led numerous business and technical projects relating to the development and production of fine chemical and pharmaceutical products by biotechnology and chemical synthesis.

He has worked closely with chemicals and pharmaceutical industry clients in identifying strategic partners and structuring relationships for technology innovation and product marketing. He has also worked in business development and merger and acquisitions with specialty chemical companies using biocatalyst technology for high-value pharmaceutical intermediates.

Dr. Armiger received a B.S.E. in Chemical Engineering cum laude from Princeton University in 1971 and a Ph.D. in Chemical and Biochemical Engineering from the University of Pennsylvania in 1977. He has been a Registered Professional Engineer since 1979.